Assessing the Clinical Impact of Biomarker Testing in Disease Management: Evaluating the Influence of Specific Biomarkers on Diagnosis and Management of Chronic Diseases in Hospitalized Patients

Authors: Maryam R. Alanazi, Monirah I. Alenazi, Loulwah A. Alhammad, Fahad A. Altheyab, Asma A. Alblaihed

DOI: https://doi.org/10.5281/zenodo.13379005

Short DOI: https://doi.org/gt7zdb

Country: Saudi Arabia

Full-text Research PDF File:   View   |   Download

Abstract: Background: Biomarker testing is increasingly utilized in the diagnosis and management of chronic diseases. However, its impact on clinical decision-making and patient outcomes in hospital settings remains underexplored.

Objective: This study aimed to assess the clinical impact of biomarker testing on the management of chronic diseases in hospitalized patients.

Methods: A retrospective analysis was conducted on hospitalized patients who underwent biomarker testing, including HbA1c, BNP, and PSA. Clinical data were extracted from electronic health records to evaluate the influence of positive biomarker results on treatment adjustments, hospital length of stay, and readmission rates.

Results: Biomarker testing significantly influenced treatment decisions, with 50% of patients with positive HbA1c results and 60% with positive BNP results undergoing changes in treatment plans. Patients with positive BNP results experienced longer hospital stays (8.0 days vs. 6.0 days) and higher readmission rates (25.0% vs. 18.0%) compared to those with negative results. Biomarker-specific impacts on clinical outcomes were observed, indicating the importance of personalized treatment approaches.

Conclusion: Biomarker testing plays a critical role in guiding treatment decisions and influencing patient outcomes in the management of chronic diseases. Further research is needed to optimize the use of biomarkers in clinical practice and explore their cost-effectiveness.

Keywords: Biomarker testing, chronic disease management, hospitalized patients, clinical outcomes, personalized medicine, electronic health records.

Paper Id: 231083

Published On: 2022-05-04

Published In: Volume 10, Issue 3, May-June 2022

Cite This: Assessing the Clinical Impact of Biomarker Testing in Disease Management: Evaluating the Influence of Specific Biomarkers on Diagnosis and Management of Chronic Diseases in Hospitalized Patients - Maryam R. Alanazi, Monirah I. Alenazi, Loulwah A. Alhammad, Fahad A. Altheyab, Asma A. Alblaihed - IJIRMPS Volume 10, Issue 3, May-June 2022. DOI 10.5281/zenodo.13379005

Share this